Target intelligence / Profile preview

Cutibacterium acnes phylotype IA1

Molecular classification
Other (Bacterial subgroup/phylotype)
01

Overview

Cutibacterium acnes phylotype IA1 is the principal subgroup of this common, Gram-positive commensal skin bacterium. It is defined by genetic, proteomic, and phenotypic markers and is most strongly associated with the development and severity of acne vulgaris[2][3][4]. Phylotype IA1 exhibits distinct surface antigens, protein expression patterns, and inflammatory potential compared to other *C. acnes* phylotypes[2][3]. It is not a target in the molecular or pharmaceutical sense, but its identification can inform disease correlations and epidemiological studies[1][4]. The IA1 phylotype is routinely detected and distinguished via molecular methods (e.g., MLST, MALDI-MS) and is used in clinical microbiology for understanding strain-specific roles in skin health and disease[1][2][3][4].

Other names
IA1 phylotypeCutibacterium acnes type IA1Propionibacterium acnes phylotype IA1 (former genus name)C. acnes IA1
02

Mechanism of action

Inhibition of bacterial protein synthesis (for macrolides and lincosamides)\nInhibition of bacterial DNA gyrase/topoisomerase (for fluoroquinolones)

03

Biological functions

Commensal skin colonizationInvolvement in pro-inflammatory responsesAssociation with biosynthetic and metabolic activity
04

Disease associations

AcneSkin inflammationPotential association with implant infections and deep tissue infections (less specific to IA1 than to broader type I phylotypes)
05

Safety considerations

Antibiotic resistance developmentNon-pathogenic colonization on skin complicates selective targeting
06

Interacting drugs

Antibiotics (erythromycin, clindamycin, moxifloxacin; interact at organism level, not specific to IA1 as a molecular target)
07

Biomarkers

Bacterial protein mass spectra (e.g., antitoxin and CsbD-like protein profiles for identification)m/z 7035 peak (MALDI-MS, specific for IA1 strains)

Beyond the preview

Go deeper on Cutibacterium acnes phylotype IA1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cutibacterium acnes phylotype IA1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call